课题基金 / 基金详情

HIV Molecular Biology and Pathogenic Mechanisms of AIDS

HIV Molecular Biology and Pathogenic Mechanisms of AIDS
HIV分子生物学与艾滋病发病机制
批准号:
7338798
负责人:
George N. Pavlakis
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

George N. Pavlakis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project aims to understand the role and mechanism of function of HIV regulation in the virus life cycle and disease development; and to dissect the mechanisms of nucleocytoplasmic trafficking of macromolecules. The conclusions of this work are also applied towards the design of better vaccine approaches against AIDS. We have focused our studies in this period on the interactions of Rev and Vpr with cellular components; and on the further understanding of posttranscriptional regulation and nucleocytoplasmic export, which are important steps in the process of gene expression. Our results contribute significantly to the further understanding of the basic mechanisms of nucleocytoplasmic traffic of macromolecules. The understanding of the regulatory mechanisms of HIV gene expression has many important practical applications. We have applied this knowledge to the development of improved DNA vaccination approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNOGENICITY & EFFICACY OF DNA VACCINES AGAINST SIV INFECTION
  • 批准号:
    7959065
  • 项目类别:
  • 资助金额:
    $10.99万
  • 财政年份:
    2009
  • 负责人:
    George N. Pavlakis
  • 依托单位:
COVID-19 vaccine development
  • 批准号:
    10487068
  • 项目类别:
  • 资助金额:
    $66.18万
  • 财政年份:
    --
  • 负责人:
    George N. Pavlakis
  • 依托单位:
HIV Molecular Biology and DNA Vaccine Approaches Against
HIV Molecular Biology and Pathogenic Mechanisms of AIDS
  • 批准号:
    7733193
  • 项目类别:
  • 资助金额:
    $44.19万
  • 财政年份:
    --
  • 负责人:
    George N. Pavlakis
  • 依托单位:
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant